Kerala Ayurveda Limited (BOM:530163)
India · Delayed Price · Currency is INR 158.05
-8.10 (-4.88%)
At close: Sep 25, 2026
Kerala Ayurveda Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 1,357 | 1,311 | 1,203 | 1,032 | 934.13 | 803.54 |
Other Revenue | - | - | - | - | 2.1 | 0.91 |
| 1,357 | 1,311 | 1,203 | 1,032 | 936.23 | 804.44 | |
Revenue Growth | 10.09% | 8.98% | 16.66% | 10.18% | 16.38% | 29.59% |
Cost of Revenue | 247.98 | 294.65 | 238.62 | 231.23 | 212.77 | 179.42 |
Gross Profit | 1,109 | 1,017 | 964.71 | 800.28 | 723.47 | 625.03 |
Selling, General & Admin | 709.29 | 840.14 | 673.27 | 391.91 | 364.26 | 282.47 |
Other Operating Expenses | 573.95 | 338.99 | 333.3 | 323.05 | 299.68 | 232.44 |
Operating Expenses | 1,340 | 1,246 | 1,068 | 736.38 | 675.01 | 526.93 |
Operating Income | -231 | -229.52 | -103.36 | 63.9 | 48.46 | 98.1 |
Interest Expense | -93.07 | -72.63 | -26.44 | -46.35 | -48.22 | -65.2 |
Interest & Investment Income | - | 0.09 | 3.35 | 1.64 | 0.77 | 2.55 |
Currency Exchange Gain (Loss) | - | 58.71 | 18.59 | 1.44 | -34.94 | -15.38 |
Other Non Operating Income (Expenses) | 50 | -0.77 | -14.42 | -14.08 | - | - |
EBT Excluding Unusual Items | -274.06 | -244.12 | -122.29 | 6.56 | -33.94 | 20.07 |
Gain (Loss) on Sale of Investments | - | 0.09 | -0.07 | - | - | - |
Gain (Loss) on Sale of Assets | - | 80.39 | - | - | - | - |
Other Unusual Items | - | - | - | - | 28.35 | 7.97 |
Pretax Income | -274.06 | -163.64 | -122.36 | 6.56 | -5.59 | 28.04 |
Income Tax Expense | -9.77 | -0.4 | 17.23 | 12.16 | -1.31 | 4.11 |
Earnings From Continuing Operations | -264.29 | -163.25 | -139.59 | -5.6 | -4.28 | 23.93 |
Minority Interest in Earnings | -0.94 | - | - | - | -4.73 | -0.32 |
Net Income | -265.23 | -163.25 | -139.59 | -5.6 | -9.01 | 23.61 |
Net Income to Common | -265.23 | -163.25 | -139.59 | -5.6 | -9.01 | 23.61 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 13 | 12 | 12 | 11 | 11 | 11 |
Shares Outstanding (Diluted) | 13 | 12 | 12 | 11 | 11 | 11 |
Shares Change | 9.91% | 0.31% | 10.28% | 3.35% | - | -0.41% |
EPS (Basic) | -20.65 | -13.53 | -11.60 | -0.51 | -0.85 | 2.24 |
EPS (Diluted) | -20.65 | -13.53 | -11.60 | -0.51 | -0.85 | 2.24 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -297.5 | -58.68 | -20.54 | 36.75 | -33.51 |
Free Cash Flow Per Share | - | -24.65 | -4.88 | -1.88 | 3.48 | -3.17 |
Gross Margin | 81.73% | 77.53% | 80.17% | 77.58% | 77.27% | 77.70% |
Operating Margin | -17.02% | -17.50% | -8.59% | 6.19% | 5.18% | 12.19% |
Profit Margin | -19.54% | -12.45% | -11.60% | -0.54% | -0.96% | 2.94% |
Free Cash Flow Margin | - | -22.68% | -4.88% | -1.99% | 3.93% | -4.17% |
EBITDA | -167.69 | -196.79 | -79.88 | 81.04 | 59.53 | 110.11 |
EBITDA Margin | -12.35% | -15.01% | -6.64% | 7.86% | 6.36% | 13.69% |
D&A For EBITDA | 63.31 | 32.72 | 23.48 | 17.14 | 11.08 | 12.02 |
EBIT | -231 | -229.52 | -103.36 | 63.9 | 48.46 | 98.1 |
EBIT Margin | -17.02% | -17.50% | -8.59% | 6.19% | 5.18% | 12.19% |
Effective Tax Rate | - | - | - | 185.41% | - | 14.66% |
Revenue as Reported | 1,407 | 1,454 | 1,222 | 1,035 | 937 | 807 |
Advertising Expenses | - | 117.11 | 91.9 | 22.81 | 43.77 | 27.31 |